Sun Pharmaceutical Share Price in Focus; Seeks Stock Exchange Approval for Promoter Group Reclassification

Written by: Team Angel OneUpdated on: 27 May 2026, 5:07 pm IST
Sun Pharmaceutical has submitted an application to stock exchanges seeking approval for the reclassification of certain shareholders from the promoter group category to the public category.
Sun Pharmaceutical Share Price
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

 Sun Pharmaceutical Industries Ltd has informed the stock exchanges that it has formally applied for the reclassification of certain shareholders from the promoter group category to the public shareholder category.  

The move follows earlier disclosures made by the company during May and is subject to regulatory review and approval by the exchanges. 

The development has been undertaken in accordance with the applicable provisions governing shareholder reclassification under listing regulations. 

Application Submitted to Stock Exchanges 

According to the company's filing, the application was submitted to the stock exchanges on May 26, 2026. The request seeks approval for shifting the identified shareholders from the promoter group classification to the public category. 

The company stated that the application has been made under the provisions governing reclassification of shareholders and follows the process prescribed under applicable securities market regulations. 

Part of Ongoing Reclassification Process 

Sun Pharma had previously informed the exchanges regarding the proposed reclassification through disclosures made earlier in May.  

The latest communication confirms that the formal application stage has now been completed and submitted for consideration by the exchanges. 

The approval process will involve examination of the application by the stock exchanges before any final decision is taken on the proposed change in shareholder classification. 

Read More: JSW Steel Plans ₹1 Trillion Investment for Integrated Greenfield Steel Plant at Dhinkia in Odisha! 

Sun Pharmaceutical Share Price Performance 

As of 27 May 2026, at 9:16 AM, Sun Pharmaceutical Industries share price is trading at ₹1,865 per share, reflecting a gain of 1.31% from the previous closing price. 

Conclusion 

Sun Pharmaceutical Industries has moved ahead with the formal application process for the reclassification of certain promoter group shareholders into the public category. The proposal will now be reviewed by the stock exchanges before any final approval is granted. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: May 27, 2026, 11:35 AM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers